IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: some miscellaneous pharmaceutical substances.
D000167:Acriflavine / Q000031:analogs & derivatives / Q000633:toxicity; D000818:Animals; D000875:Anthralin / Q000633:toxicity; D006051:Aurothioglucose / Q000633:toxicity; D002273:Carcinogens / Q000378:metabolism; D002738:Chloroquine / Q000633:toxicity; D003975:Diazepam / Q000633:toxicity; D004983:Ethanolamines / Q000633:toxicity; D005000:Ethionamide / Q000633:toxicity; D005260:Female; D006801:Humans; D006826:Hycanthone / Q000633:toxicity; D008297:Male; D008795:Metronidazole / Q000633:toxicity; D009369:Neoplasms / Q000139:chemically induced*; D009374:Neoplasms, Experimental / Q000139:chemically induced; D010076:Oxazepam / Q000633:toxicity; D010110:Oxymetholone / Q000633:toxicity; D010113:Oxyphenbutazone / Q000633:toxicity; D015125:Oxyquinoline / Q000633:toxicity; D010615:Phenacetin / Q000633:toxicity; D010634:Phenobarbital / Q000633:toxicity; D010653:Phenylbutazone / Q000633:toxicity; D010672:Phenytoin / Q000633:toxicity; D011247:Pregnancy; D011739:Pyrimethamine / Q000633:toxicity; D012306:Risk
D002273:Carcinogens; D004983:Ethanolamines; D008795:Metronidazole; D000167:Acriflavine; D006826:Hycanthone; D006051:Aurothioglucose; D015125:Oxyquinoline; D010672:Phenytoin; D010076:Oxazepam; D002738:Chloroquine; D010615:Phenacetin; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D010110:Oxymetholone; D005000:Ethionamide; D003975:Diazepam; D000875:Anthralin; D010634:Phenobarbital; D011739:Pyrimethamine